Introduction
Esophageal cancer is one of the most common malignant tumors of the digestive system in the world. There are about 240,000 new cases of esophageal cancer in China every year. [1] [2] [3] According to statistics, its 5-year survival rate is 3.5%-13.9% in Xinjiang. The cancer mortality rate is 13.05/100,000, of which the Kazakh (Ha) mortality rate is 68.88/100,000, which seriously threatens people's health.
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liu et al and metastasis of digestive tract tumors in a variety of ways, and is related to monocyte activation antigen and matrix metalloproteinase production. 9 Studies have shown that 10 uPA mainly participates in the inhibition of excessive degradation of extracellular matrix (ECM) through the urokinase-type plasminogen activator receptor (uPAR)/plasminogen activator inhibitor type 1 (PAI-1) complex, thereby inhibiting tumor metastasis. Recently, more studies have shown [11] [12] [13] [14] that uPA may be associated with the mitogen-activated protein kinase 38 (p38MAPK) signaling pathway in a variety of tumor progression, and is found to be highly expressed in both tumors and associated with clinical stage and lymph node metastasis, such as in breast cancer, ovarian cancer, and lung cancer. It was also found that blocking the p38MAPK signaling pathway in ovarian cancer, can inhibit uPA expression. The p38MAPK signaling pathway can inhibit uPA expression. Although some progress has been made on this research, there are few more detailed studies on them, such as whether p38MAPK participates in the formation of uPA/uPAR/PAI-1 and affects the degradation of the outer matrix (ECM), or their relationship in the esophagus carcinoma progression.
P38 is an important member of the mitogen-activated protein kinase (MAPK), which has six isoforms, p38α1, p38α2, p38β1, p38β2, p38γ, and p38δ. Studies have found that extracellular stimuli such as cytokines and bacterial pathogens can activate the phosphorylation of the Thr site of p38MAPK, which transduces signals to the nucleus to initiate related target genes to promote transcription. [15] [16] [17] p38MAPK is known to be involved in a variety of different biological processes, including promoting apoptosis, participating in inflammatory reactions, malignant tumor development, and regulating transcription and translation of many different proteins, but its research in esophageal cancer is relatively rare. In our previous study, we found that uPA and p38MAPK may be closely related to esophageal cancer. The purpose of this study was to investigate the relationship between the two in esophageal cancer and its relationship with clinicopathological features and prognosis of esophageal cancer.
Materials and methods Materials
One hundred eighty-four cases of esophageal cancer specimens confirmed by pathology in the First Affiliated Hospital of Sun Yat-sen University from 2007 to 2011 and 62 cases of adjacent normal tissues (5 cm from the edge of esophageal cancer, pathologically confirmed normal mucosal tissue) were selected. All cases were not given any radiotherapy or chemotherapy before surgery. The results were independently read by three pathologists and scored according to the intensity of staining and the percentage of positive cells. Ten high-power fields of each slice were selected, and the percentage of positive cells was counted. The scoring criteria were as follows: no positive cells, 0; 25%, 1; 25%-50%, 2; 50%-75%, 3; 75%, 4. Staining intensity score criteria: no coloring, 0; light yellow, 1; brownish yellow, 2; tan, 3. The final staining results were multiplied by the percentage of positive cells and staining intensity, with 0-2 being negative and 3 being positive.
Western blotting
One hundred microliters of RIPA lysate was added to 20 mg of tissue, homogenized on ice, centrifuged at 12,000 rev/minute for 10 minutes at 4°C, and the supernatant was separated to determine the protein concentration. The protein was separated by 10% SDS-PAGE electrophoresis with a loading of 40 µg in a volume of 20 µL. After the electrophoresis, a "sandwich" was prepared, and the protein was electrotransferred to the PVDF membrane. After blocking with 5% nonfat dry milk for 2 hours, added anti-uPA (1:600), anti-p38MAPK (1:500), and mouse anti-β-actin (clone AC-15; 1:10,000, Sigma-Aldrich). After washing the membrane, added the secondary antibody, incubated for 50 minutes at room temperature on the shaker. At the end, the membrane was washed five times with TBST for 5 minutes each time, and the ECL was exposed. Gelpro 32 analysis was performed for gel image analysis.
statistical methods
Data were analyzed using Graphpad Prism 6.0 software. Count data were expressed as rates and chi-squared tests were used for comparison between groups. Spearman test was used for correlation analysis and Kaplan-Meier and Cox proportional hazards regression were used for univariate and multivariate analyses. P0.05 was considered statistically significant. "*" stands for "P0.01," "**" stands for "P0.001," "***" stands for "P0.0001."
Results
expressions of uPa and p38MaPK in esophageal cancer and adjacent tissues
After immunohistochemistry test, according to the above methods, the expressions of uPA and p38MAPK in esophageal squamous cell carcinoma and adenocarcinoma were found to be higher than those in normal esophageal tissues (both relationship between uPa, p38MaPK, and prognosis in patients with esophageal cancer After Kaplan-Meier analysis, the survival time of uPA-and p38MAPK-positive expression patients was found to be significantly shorter than that of negative patients (former, median survival: 42 vs 96 months, P0.0001; latter, median survival: 45 vs 78 months, P=0.0121). At the same time, it was found that patients with uPA-positive expression had a shorter progression-free time than negative patients (Median time:16 vs 70 months, P=0.0032), whereas there was no significant difference between p38MAPK-positive and p38MAPK-negative patients ( Figure 2 and Table 3) .
Cox multivariate regression analysis was performed based on patient age, gender, depth of tumor invasion, lymph node metastasis, lesion length, pTNM, uPA, and p38MAPK protein expressions. The results showed that uPA, p38MAPK protein expressions, and pTNM staging were independent prognostic factors ( 
Discussion
Esophageal cancer is one of the most common malignant tumors in the world and is one of the important threats to human life. 18, 19 At present, after extensive research, the diagnosis and treatment of esophageal cancer has been greatly expanded, mainly including chemotherapy and surgical treatment. However, the recurrence rate and metastasis rate are still high, which is an important limitation that restricts the therapeutic effect. [20] [21] [22] This study explored the relationship between uPA, p38MAPK, and esophageal cancer, explored its possible mechanism, and provided a preliminary scientific basis for expanding the new diagnosis and treatment of esophageal cancer.
A number of studies have confirmed that uPA plays an important role in tumor progression in a variety of tissues, such as breast cancer and ovarian cancer, [23] [24] [25] which is often 26 found that the positive expression of uPA was significantly higher in patients with distant metastasis of esophageal squamous cell carcinoma than in patients without distant metastasis. The higher the tumorigenicity of esophageal squamous cell carcinoma with higher uPA expression, the stronger is the tumor invasiveness and the tumor growth, suggesting that uPA may be involved in the occurrence and development of esophageal squamous cell carcinoma, participating in tumor tissue angiogenesis, and facilitating tumor cell metastasis. These data are consistent with our findings. In this study, the expression of uPA in esophageal squamous cell carcinoma and adenocarcinoma was much higher than that in normal esophageal tissue, suggesting that it may bear an important role in esophageal cancer progression.
MAPK is an important key molecule in the cell signaling pathway. p38 is one of its family members. When activated by upstream signals, p38 transmits cytoplasmic signals to the nucleus, activates specific nuclear transcription factors, regulates target genes, and participates in regulating cell growth and differentiation. p38 has six different subtypes, and its biological effects may differ under different cells and stimuli. Kim et al 27 found that inhibition of p38MAPK activity can reduce the ability of cancer cells to exercise and reduce invasion and metastasis. Studies on human choriocarcinoma have shown that activated p38 enhances the invasive behavior of human trophoblast cells and plays an important role in the formation of choriocarcinoma. 15, 16, 28 This study showed that the expressions of uPA and p38MAPK in esophageal cancer tissues were much higher than those in adjacent normal esophageal tissues, suggesting that both proteins may play an important role in the progression of esophageal cancer. Further analysis revealed that there is a close positive correlation between the expressions of both proteins. These data suggest an important possibility: do not rule out the role of uPA and p38MAPK in promoting the progression of esophageal cancer in the same pathway. Considering p38MAPK as a key molecule for several important signaling pathways, 29, 30 we believe that uPA may be involved either upstream or downstream of it. The conclusion of this study has not been reported yet. Although this study only analyzes semiquantitative immunohistochemistry and there is no further observation and determination of the relationship between the two proteins, it provides an important direction for revealing the mechanism of esophageal cancer progression.
In further analysis of its relationship with clinical pathological parameters of patients with esophageal cancer, the close relationship between them is further indicated. We found that the positive expressions of uPA and p38MAPK are closely related to the cancer size, depth of invasion, and pathological stage of esophageal cancer. This confirms that both proteins are involved in the progression of esophageal cancer, which is consistent with some conclusions about the relationship among uPA, p38MAPK, and esophageal cancer. [31] [32] [33] In these studies, uPA or p38MAPK was also observed to be closely related to esophageal cancer size and pTNM staging. In this study, we also found that uPA has no significant relationship with esophageal cancer tissue type, and p38MAPK is relatively high in adenocarcinoma. This phenomenon has attracted our attention, which may suggest Notes: The median survival time of patients with positive expression of both proteins was significantly shorter than that of patients with negative expression. Meanwhile, the time to progression of uPA-positive patients was shortened, but there was no significant difference between the time of progression of p38MAPK-positive patients and p38MaPK-negative patients. Abbreviation: p38MaPK, mitogen-activated protein kinase 38; uPa, urokinase-type plasminogen activator. In the analysis, we performed a complete prognosis of overall survival and progression-free prognosis for 184 patients. The similarity in characteristics and functions of the two were observed again. We found that the median survival time of patients with positive protein expression was significantly shortened, which is consistent with the above data and also with most of research on their relationship between single uPA or p38MAPK and esophageal cancer. 31, 34, 35 At the same time, we found that only the uPA-positive patients had a significant reduction in the progression-free time, and the p38MAPK-positive patients did not significantly shorten the progression time. For the cause of this phenomenon, we consider not to rule out the possible errors caused by follow-up data collection (accurate time for progression-free progress has an error). In further Cox multivariate analysis, this study found that both proteins and pTNM staging can be used as independent prognostic factors for esophageal cancer.
In this study, we found that uPA and p38MAPK proteins may play important roles in the progression of esophageal cancer, and there may be synergistic effects in this process, which provide a new perspective for us to further explore the mechanism of esophageal cancer progression. At present, the diagnosis and treatment of esophageal cancer mainly depends on surgery and chemotherapy, which has a great impact on the quality of life of patients and has limitations. Therefore, these results are of great value to explore novel treatment methods. The role of uPA and p38MAPK in the progression of esophageal cancer may provide a scientific basis for exploring the feasibility of biologically targeted therapy for esophageal cancer.
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